Items where Author is "Walter, M. A."

2015

Schandelmaier, S. and Conen, K. and von Elm, E. and You, J. J. and Blümle, A. and Tomonaga, Y. and Saccilotto, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital of Basel and Switzerland., and Amstutz, A. and Bengough, T. and Meerpohl, J. J. and Stegert, M. and Olu, K. K. and Tikkinen, K. A. O. and Neumann, I. and Carrasco-Labra, A. and Faulhaber, M. and Mulla, S. M. and Mertz, D. and Akl, E. A. and Sun, X. and Bassler, D. and Busse, J. W. and Ferreira-González, I. and Lamontagne, F. and Nordmann, A. and Gloy, V. and Raatz, H. and Moja, L. and Rosenthal, R. and Ebrahim, S. and Vandvik, P. O. and Johnston, B. C. and Walter, M. A. and Burnand, B. and Schwenkglenks, M. and Hemkens, L. G. and Bucher, H. C. and Guyatt, G. H. and Briel, M. and Kasenda, B. and Disco study group, . (2015) Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26 (9). pp. 1966-1973.

Mueller, B. and Hieber, S. E. and Zumbuehl, A. and Walter, M. A. and Huwyler, J. and Pfohl, T. and Cattin, Ph. C.. (2015) Translational Medicine: Nanoscience and Nanotechnology to Improve Patient Care. In: The Nano-Micro Interface: Bridging the Micro and Nano Worlds. Weinheim, pp. 291-309.

2014

Romer, A. and Seiler, D. and Marincek, N. and Brunner, P. and Koller, M. T. and Ng, Q. K. T. and Maecke, H. R. and Müller-Brand, J. and Rochlitz, C. and Briel, M. and Schindler, C. and Walter, M. A.. (2014) Somatostatin-based radiopeptide therapy with [(177)Lu-DOTA]-TOC versus [ (90)Y-DOTA]-TOC in neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, Vol. 41, H. 2. pp. 214-222.

2013

Marincek, N. and Jorg, A. C. and Brunner, P. and Schindler, C. and Koller, M. T. and Rochlitz, C. and Muller-Brand, J. and Maecke, H. R. and Briel, M. and Walter, M. A.. (2013) Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study. Journal of translational medicine, Vol. 11 , 17. p. 17.

2012

Villard, L. and Romer, A. and Marincek, N. and Brunner, P. and Koller, M. T. and Schindler, C. and Ng, Q. K. and Macke, H. R. and Muller-Brand, J. and Rochlitz, C. and Briel, M. and Walter, M. A.. (2012) Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 30, H. 10. pp. 1100-1106.

2011

Imhof, A. and Brunner, P. and Marincek, N. and Briel, M. and Schindler, C. and Rasch, H. and Macke, H. R. and Rochlitz, C. and Muller-Brand J., and Walter, M. A.. (2011) Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, H. 17. pp. 2416-2423.

2009

Walter, M. A. and Schindler, C. and Christ-Crain, M. and Muller-Brand, J. and Muller, B.. (2009) Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models. European Journal of Clinical Investigation, 39 (1). pp. 51-57.

2008

Walter, M. A. and Christ-Crain, M. and Muller, B.. (2008) Graves' disease. The New England journal of medicine, Vol. 359 , S. 1407 ; author reply 1409.

2007

Walter, M. A. and Briel, M. and Christ-Crain, M. and Bonnema, S. J. and Connell, J. and Cooper, D. S. and Bucher, H. C. and Muller-Brand, J. and Muller, B.. (2007) Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. Bmj, 334 (7592). p. 514.

Iten, F. and Muller, B. and Muller-Brand, J. and Walter, M. A.. (2007) Nuklearmedizin: Die systemische Radionuklidtherapie beim metastasierten medullären Schilddrüsenkarzinom. Schweizerisches Medizin-Forum, 7 (1). pp. 21-22.

Iten, F. and Muller, B. and Schindler, C. and Rochlitz, C. and Oertli, D. and Macke, H. R. and Muller-Brand, J. and Walter, M. A.. (2007) Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clinical Cancer Research, 13 (22). pp. 6696-6702.

Walter, M. A. and Turtschi, C. P. and Schindler, C. and Minnig, P. and Muller-Brand, J. and Muller, B.. (2007) The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study. Journal of Nuclear Medicine, 48 (10). pp. 1620-1625.

2006

Walter, M. A. and Seboek, D. and Demougin, P. and Bubendorf, L. and Oberholzer, M. and Muller-Brand, J. and Muller, B.. (2006) Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues. Pathology, 38 (3). pp. 249-253.

Walter, M. A. and Christ-Crain, M. and Schindler, C. and Muller-Brand, J. and Muller, B.. (2006) Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6). pp. 730-737.

2005

Walter, M. A. and Christ-Crain, M. and Muller, B. and Muller-Brand, J.. (2005) Radioiodine uptake and thyroid hormone levels on or off simultaneous carbimazole medication: a prospective paired comparison. Nuklearmedizin, 44 (1). pp. 33-36.

2004

Walter, M. A. and Christ-Crain, M. and Eckard, B. and Schindler, C. and Nitzsche, E. U. and Muller-Brand, J. and Muller, B.. (2004) Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. European Journal of Clinical Investigation, 34 (5). pp. 365-370.